Amprius Technologies Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | -$0.0200 |
| EPS actual | -$0.0400 |
| EPS Surprise | -100.00% |
| Revenue estimate | 25.723M |
| Revenue actual | 28.536M |
| Revenue Surprise | 10.93% |
| Release date | Mar 04, 2026 |
| EPS estimate | -$0.0380 |
| EPS actual | -$0.0100 |
| EPS Surprise | 73.67% |
| Revenue estimate | 22.909M |
| Revenue actual | 25.234M |
| Revenue Surprise | 10.15% |
| Release date | Nov 06, 2025 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.0300 |
| EPS Surprise | 50.00% |
| Revenue estimate | 22.973M |
| Revenue actual | 21.426M |
| Revenue Surprise | -6.73% |
| Release date | Aug 07, 2025 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0500 |
| EPS Surprise | 37.50% |
| Revenue estimate | 12.415M |
| Revenue actual | 15.067M |
| Revenue Surprise | 21.36% |
Last 4 Quarters for Amprius Technologies
Below you can see how AMPX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $7.72 |
| EPS estimate | -$0.0800 |
| EPS actual | -$0.0500 |
| EPS surprise | 37.50% |
| Date | Price |
|---|---|
| Aug 01, 2025 | $6.36 |
| Aug 04, 2025 | $7.54 |
| Aug 05, 2025 | $8.32 |
| Aug 06, 2025 | $7.90 |
| Aug 07, 2025 | $7.72 |
| Aug 08, 2025 | $8.06 |
| Aug 11, 2025 | $7.69 |
| Aug 12, 2025 | $7.76 |
| Aug 13, 2025 | $7.67 |
| 4 days before | 21.38% |
| 4 days after | -0.648% |
| On release day | 4.40% |
| Change in period | 20.60% |
| Release date | Nov 06, 2025 |
| Price on release | $11.26 |
| EPS estimate | -$0.0600 |
| EPS actual | -$0.0300 |
| EPS surprise | 50.00% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $14.09 |
| Nov 03, 2025 | $13.56 |
| Nov 04, 2025 | $12.10 |
| Nov 05, 2025 | $13.04 |
| Nov 06, 2025 | $11.26 |
| Nov 07, 2025 | $12.73 |
| Nov 10, 2025 | $13.59 |
| Nov 11, 2025 | $12.92 |
| Nov 12, 2025 | $12.37 |
| 4 days before | -20.09% |
| 4 days after | 9.86% |
| On release day | 13.06% |
| Change in period | -12.21% |
| Release date | Mar 04, 2026 |
| Price on release | $12.55 |
| EPS estimate | -$0.0380 |
| EPS actual | -$0.0100 |
| EPS surprise | 73.67% |
| Date | Price |
|---|---|
| Feb 26, 2026 | $11.52 |
| Feb 27, 2026 | $10.73 |
| Mar 02, 2026 | $11.59 |
| Mar 03, 2026 | $11.63 |
| Mar 04, 2026 | $12.55 |
| Mar 05, 2026 | $14.89 |
| Mar 06, 2026 | $16.33 |
| Mar 09, 2026 | $17.72 |
| Mar 10, 2026 | $18.00 |
| 4 days before | 8.94% |
| 4 days after | 43.43% |
| On release day | 18.65% |
| Change in period | 56.25% |
| Release date | May 06, 2026 |
| Price on release | $22.19 |
| EPS estimate | -$0.0200 |
| EPS actual | -$0.0400 |
| EPS surprise | -100.00% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $21.06 |
| May 01, 2026 | $20.86 |
| May 04, 2026 | $20.38 |
| May 05, 2026 | $21.40 |
| May 06, 2026 | $22.19 |
| May 07, 2026 | $16.11 |
| May 08, 2026 | $16.70 |
| May 11, 2026 | $17.68 |
| May 12, 2026 | $18.83 |
| 4 days before | 5.37% |
| 4 days after | -15.14% |
| On release day | -27.40% |
| Change in period | -10.59% |
Amprius Technologies Earnings Call Transcript Summary of Q1 2026
Amprius reported a strong Q1 2026 with revenue of $28.5M (up 153% YoY, +13% sequential), driven by adoption of its second-generation SiCore silicon-anode cells across UAS (drones), light electric vehicles (LEVs), and growing traction in the U.S. defense market. Management raised 2026 revenue guidance to at least $130M (previously $125M) and reiterated adjusted EBITDA guidance of at least $4M and a net loss no worse than $8M. Key commercial highlights include $21M multi‑quarter LEV order from a leading Chinese customer, expanded DIU (Defense Innovation Unit) contract now totaling $18.1M to develop standardized pouch and cylindrical NDAA‑compliant cells, and three long‑standing customers receiving large defense awards that increase visibility into future battery demand. Q1 gross margin was 20% (22% ex‑one month Colorado carry), with management attributing the sequential margin step‑back to remaining SiMaxx overhead and one month of Colorado costs; they expect margins to improve later in the year toward the 25% target as mix, logistics, and additional CM capacity normalize. Cash totaled $62.4M at quarter end (down from $90.5M), reflecting higher receivables, a $20M settlement of the Colorado lease obligation (which reduced liabilities by $29.8M), and DIU‑funded CapEx. Manufacturing buildout progress includes technical validation with Nanotech (U.S. 21700 cylindrical cell) and multiple contract manufacturers in Korea; management expects more U.S./allied manufacturing partners to be announced when ready. The company also announced an agreement to exchange ~7.1M public warrants into common shares to reduce future dilution (management estimates >$70M of avoided dilution), simplify the capital structure and potentially relieve related short interest. Overall, Amprius is emphasizing commercialization, standardization for defense procurement, expansion of pack partner distribution, and continued investment in sales/GT M to capture accelerating demand across high energy density markets (UAS, satellites/space, LEV, robotics, eVTOL).
Sign In
Buy AMPX